Literature DB >> 21031339

Obesity of TallyHO/JngJ mouse is due to increased food intake with early development of leptin resistance.

S D Rhee1, Y Y Sung, Y S Lee, J Y Kim, W H Jung, M J Kim, M-S Lee, M K Lee, S-D Yang, H G Cheon.   

Abstract

TALLYHO/JngJ (TallyHo) mouse is a recently established animal model for type 2 diabetes mellitus (T2DM) with phenotypes of mild obesity and male-limited hyperglycemia. In this study, we investigated how obesity develops in TallyHo mice by measuring parameters of food intake and energy expenditure. At 4 weeks of age, TallyHo mice were heavier than control C57BL/6 mice with increased food intake but comparable energy expenditure parameters, such as body temperature, cold-induced thermogenesis, oxygen consumption rate (VO(2)) and spontaneous locomotor activity. Furthermore, pair-fed TallyHo mice, which were fed the same amount of food as C57BL/6 mice, showed similar patterns of body weight gain to C57BL/6 mice at all ages, implying that obesity in TallyHo mice may develop by increased food intake but not by decreased energy consumption. TallyHo mice appear to have hypothalamic leptin resistance at 4 weeks of age, as indicated by the increased expression of orexigenic neuropeptides in the hypothalamus and no alteration of food intake and neuropeptide expression upon intravenous leptin treatment. Leptin injection to TallyHo mice, however, increased the phosphorylation of STAT3 and Akt, an important signaling mediator of leptin, in a pattern similar to that in C57BL/6 mice. In conclusion, increased food intake is a crucial component in the development of obesity in TallyHo mice, in which central leptin resistance, possibly caused by uncoupling between activation of leptin signaling and neuropeptide expression, might be involved. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21031339     DOI: 10.1055/s-0030-1267202

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  5 in total

Review 1.  Laboratory animals as surrogate models of human obesity.

Authors:  Cecilia Nilsson; Kirsten Raun; Fei-fei Yan; Marianne O Larsen; Mads Tang-Christensen
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age.

Authors:  Amy Creecy; Sasidhar Uppuganti; Mustafa Unal; R Clay Bunn; Paul Voziyan; Jeffry S Nyman
Journal:  Bone       Date:  2018-02-10       Impact factor: 4.398

Review 3.  The role of leptin in obesity and the potential for leptin replacement therapy.

Authors:  Helin Feng; Lihua Zheng; Zhangying Feng; Yaheng Zhao; Ning Zhang
Journal:  Endocrine       Date:  2012-12-29       Impact factor: 3.633

4.  Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo/JngJ mice.

Authors:  Hee Yeon Won; Jin-Ah Lee; Zong Sik Park; Jin Sook Song; Hee Yun Kim; Su-Min Jang; Sung-Eun Yoo; Youmi Rhee; Eun Sook Hwang; Myung Ae Bae
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

5.  Inhibition of intestinal villus cell Na/K-ATPase mediates altered glucose and NaCl absorption in obesity-associated diabetes and hypertension.

Authors:  Balasubramanian Palaniappan; Subha Arthur; Vijaya Lakshmi Sundaram; Molly Butts; Shanmuga Sundaram; Kathiresh Mani; Soudamani Singh; Niraj Nepal; Uma Sundaram
Journal:  FASEB J       Date:  2019-05-20       Impact factor: 5.834

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.